• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室恒河猴(Macaca mulatta)接种 SARS-CoV-2 疫苗的监测和免疫原性。

Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta).

机构信息

Brain Research Institute, University of Bremen, Bremen, Germany.

Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.

出版信息

Sci Rep. 2023 Feb 25;13(1):3274. doi: 10.1038/s41598-023-30473-7.

DOI:10.1038/s41598-023-30473-7
PMID:36841887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9958316/
Abstract

The availability of effective vaccines and a high vaccination rate allowed the recent mitigation, or even withdrawal, of many protective measures for containing the SARS CoV-2 pandemic. At the same time, new and highly mutated variants of the virus are found to have significantly higher transmissibility and reduced vaccine efficacy, thus causing high infection rates during the third year of the pandemic. The combination of reduced measures and increased infectivity poses a particular risk for unvaccinated individuals, including animals susceptible to the virus. Among the latter, non-human primates (NHPs) are particularly vulnerable. They serve as important models in various fields of biomedical research and because of their cognitive capabilities, they receive particular attention in animal welfare regulations around the world. Yet, although they played an extraordinarily important role for developing and testing vaccines against SARS-CoV-2, the protection of captive rhesus monkeys against Covid-19 has rarely been discussed. We here report upon twofold mRNA vaccination of a cohort of 19 elderly rhesus monkeys (Macaca mulatta) against infection by SARS-CoV-2. All animals were closely monitored on possible side effects of vaccination, and were tested for neutralising antibodies against the virus. The data show that vaccination of rhesus monkeys is a safe and reliable measure to protect these animals against SARS-CoV-2.

摘要

有效的疫苗和高接种率使得最近能够缓解甚至取消许多控制 SARS-CoV-2 大流行的保护措施。与此同时,人们发现该病毒的新的、高度变异的变体具有更高的传染性和降低的疫苗效力,从而导致大流行的第三年感染率很高。措施减少和传染性增加的结合对未接种疫苗的个体,包括易感染该病毒的动物构成了特别的风险。在后一种情况下,非人类灵长类动物(NHPs)特别容易受到感染。它们是非人类灵长类动物在各种生物医学研究领域的重要模型,并且由于它们的认知能力,它们在全球动物福利法规中受到特别关注。然而,尽管它们在开发和测试针对 SARS-CoV-2 的疫苗方面发挥了非常重要的作用,但针对新冠病毒对圈养恒河猴的保护作用却很少被讨论。我们在这里报告了对一组 19 只老年恒河猴(Macaca mulatta)进行双重 mRNA 疫苗接种以预防 SARS-CoV-2 感染的情况。所有动物都密切监测接种疫苗的可能副作用,并测试针对该病毒的中和抗体。数据表明,对恒河猴进行疫苗接种是一种安全可靠的措施,可以保护这些动物免受 SARS-CoV-2 的侵害。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/5a282a3a9e5d/41598_2023_30473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/55ee1eb3df9d/41598_2023_30473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/1a446dc6c020/41598_2023_30473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/5a282a3a9e5d/41598_2023_30473_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/55ee1eb3df9d/41598_2023_30473_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/1a446dc6c020/41598_2023_30473_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7431/9968308/5a282a3a9e5d/41598_2023_30473_Fig3_HTML.jpg

相似文献

1
Monitoring and immunogenicity of SARS-CoV-2 vaccination of laboratory rhesus monkeys (Macaca mulatta).实验室恒河猴(Macaca mulatta)接种 SARS-CoV-2 疫苗的监测和免疫原性。
Sci Rep. 2023 Feb 25;13(1):3274. doi: 10.1038/s41598-023-30473-7.
2
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates.在非人灵长类动物中,一种新型冠状病毒重组植物源性病毒样颗粒候选疫苗的无佐剂和佐剂制剂的安全性、免疫原性和保护作用。
Cell Mol Immunol. 2022 Feb;19(2):222-233. doi: 10.1038/s41423-021-00809-2. Epub 2022 Jan 5.
3
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性:一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
4
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.一种基于人体细胞的 SARS-CoV-2 疫苗可引发强烈的中和抗体反应,并可保护小鼠免受 SARS-CoV-2 攻击。
Emerg Microbes Infect. 2021 Dec;10(1):1555-1573. doi: 10.1080/22221751.2021.1957400.
5
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.基于衣壳病毒样颗粒的 SARS-CoV-2 疫苗可诱导高水平抗体并保护恒河猴。
Front Immunol. 2022 Apr 5;13:857440. doi: 10.3389/fimmu.2022.857440. eCollection 2022.
6
Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study.用于 SARS-CoV-2 的 BIV1-CovIran 灭活候选疫苗的安全性和效力:一项临床前研究。
Rev Med Virol. 2022 May;32(3):e2305. doi: 10.1002/rmv.2305. Epub 2021 Oct 26.
7
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.三剂原型 SARS-CoV-2 灭活疫苗可诱导针对其关切变异株的交叉保护。
Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4.
8
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models.灭活 SARS-CoV-2 疫苗产生的抗体衰减提供了针对感染的保护,而不会在恒河猴肺炎模型中引起抗体增强的免疫病理学。
Emerg Microbes Infect. 2021 Dec;10(1):2194-2198. doi: 10.1080/22221751.2021.2002670.
9
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.一种新型 RBD 蛋白/肽疫苗可诱导广泛中和抗体,并保护小鼠和猕猴免受 SARS-CoV-2 感染。
Emerg Microbes Infect. 2022 Dec;11(1):2724-2734. doi: 10.1080/22221751.2022.2140608.
10
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.婴儿恒河猴接种 SARS-CoV-2 疫苗后,1 年后可预防异源病毒攻击。
Sci Transl Med. 2023 Mar;15(685):eadd6383. doi: 10.1126/scitranslmed.add6383. Epub 2023 Mar 1.

引用本文的文献

1
A review of the scientific literature on experimental toxicity studies of COVID-19 vaccines, with special attention to publications in toxicology journals.对 COVID-19 疫苗实验毒性研究的科学文献综述,特别关注毒理学杂志上的出版物。
Arch Toxicol. 2024 Nov;98(11):3603-3617. doi: 10.1007/s00204-024-03854-8. Epub 2024 Sep 3.
2
Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models.新型冠状病毒病的免疫生物学:来自动物模型的机制和治疗见解。
Zool Res. 2024 Jul 18;45(4):747-766. doi: 10.24272/j.issn.2095-8137.2024.062.
3
Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines.

本文引用的文献

1
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later.婴儿恒河猴接种 SARS-CoV-2 疫苗后,1 年后可预防异源病毒攻击。
Sci Transl Med. 2023 Mar;15(685):eadd6383. doi: 10.1126/scitranslmed.add6383. Epub 2023 Mar 1.
2
SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19.SARS-CoV-2 感染神经元并在 COVID-19 的非人类灵长类动物模型中引发神经炎症。
Cell Rep. 2022 Nov 1;41(5):111573. doi: 10.1016/j.celrep.2022.111573. Epub 2022 Oct 12.
3
Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75.
COVID-19 疫苗接种的非人类灵长类动物和人类的时间免疫反应动力学。
PLoS One. 2023 Oct 19;18(10):e0287377. doi: 10.1371/journal.pone.0287377. eCollection 2023.
奥密克戎亚谱系BA.2.75的肺细胞进入、细胞间融合能力及中和敏感性
Lancet Infect Dis. 2022 Nov;22(11):1537-1538. doi: 10.1016/S1473-3099(22)00591-6. Epub 2022 Sep 15.
4
COVID-19 vaccination in animals: A strategy for combating the global outbreak.动物中的新冠病毒疫苗接种:应对全球疫情的一项策略。
Int J Surg. 2022 Sep;105:106848. doi: 10.1016/j.ijsu.2022.106848. Epub 2022 Aug 24.
5
Update on the omicron sub-variants BA.4 and BA.5.关于奥密克戎亚变体 BA.4 和 BA.5 的最新信息。
Rev Med Virol. 2023 Jan;33(1):e2391. doi: 10.1002/rmv.2391. Epub 2022 Aug 26.
6
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.奥密克戎变异株疫苗有效性的系统评价和荟萃分析。
Front Public Health. 2022 Jul 13;10:940956. doi: 10.3389/fpubh.2022.940956. eCollection 2022.
7
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.奥密克戎刺突功能和中和活性由一组全面的疫苗引发。
Science. 2022 Aug 19;377(6608):890-894. doi: 10.1126/science.abq0203. Epub 2022 Jul 19.
8
Besides human booster doses: Could vaccinating highly susceptible animals to SARS-CoV-2 be the needed urgent strategic step?除了人类加强针:给对新冠病毒高度易感的动物接种疫苗会是必要的紧急战略举措吗?
Int J Surg. 2022 Aug;104:106761. doi: 10.1016/j.ijsu.2022.106761. Epub 2022 Jul 5.
9
Developing and validating SARS-CoV-2 assays for nonhuman primate surveillance.开发和验证用于非人类灵长类动物监测的 SARS-CoV-2 检测方法。
J Med Primatol. 2022 Oct;51(5):264-269. doi: 10.1111/jmp.12604. Epub 2022 Jul 6.
10
Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5.新出现的奥密克戎亚变体BA.2.12.1、BA.4和BA.5的中和抗性增强
Lancet Infect Dis. 2022 Aug;22(8):1117-1118. doi: 10.1016/S1473-3099(22)00422-4. Epub 2022 Jun 28.